Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQWD3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,610
Award facts
- Contract value 100% obligated
- $39,609.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at approximately $39.6K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. The delivery order, issued on November 24, 2025, represents one of numerous recent procurement actions through DMS Pharmaceutical Group's Indefinite Delivery Contract under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This broader contract vehicle, awarded on November 13, 2025, carries a ceiling value of $499.999B and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a critical regional pharmaceutical supplier for Department of Defense healthcare operations worldwide.
The delivery order carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group has maintained continuous federal contracting activity as a SAM-registered entity since July 2001 and serves as a single-award prime vendor under the PPV-G GEN V program, which is part of the Defense Logistics Agency's broader $30.3B pharmaceutical supply chain modernization strategy. The company supplies an extensive portfolio of pharmaceuticals and medical consumables directly to military healthcare facilities, with performance on this and related delivery orders supporting the Department of Defense's recurring medical supply requirements across its global network of medical facilities.
Quick answers
Who was awarded contract SPE2DR26FQWD3?
SPE2DR26FQWD3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FQWD3 worth?
The government has obligated $39,610 on SPE2DR26FQWD3.
Is contract SPE2DR26FQWD3 an order under another contract?
Yes. SPE2DR26FQWD3 is a delivery order under SPE2DR25D9353, an indefinite delivery contract.
Was contract SPE2DR26FQWD3 competed?
The extent of competition for SPE2DR26FQWD3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award